Egis World
Egis' products are sold to 100 countries.

Egis keeps growing in OTC markets via acquisition

Egis Pharmaceuticals PLC acquired Sinuforte from Hartington Business S.L. Under the agreement Egis receives all rights related to the product, a nasal spray indicated for the treatment of sinusitis and other inflammatory diseases of the paranasal sinuses. The company seeks to ensure its growing presence in major export markets through organic growth and targeted acquisitions.

More

Egis keeps growing in OTC markets via acquisition

Egis Pharmaceuticals PLC has acquired Sorbifer’s product rights from AstraZeneca. The transaction reinforces Egis’ position on its key markets.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox